Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solural Pharma
Ballerup, Region Hovedstaden, Denmarkscantox.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Phase 2
01
Overview
Solural Pharma was a Danish specialty pharma CDMO focused on developing innovative oral drug formulations with unique benefits in efficacy, safety, and convenience. The company provided end-to-end pharmaceutical development services—including consultancy in CMC development and project management—primarily targeting low-solubility small molecules. In November 2023, it was acquired by Scantox and now operates as Scantox Ballerup.
- Therapeutic areas
- Other
- Modalities
- Small molecule
- Industry
- Drug Discovery Services
02
Partnerships
Works with partners and CROs to develop new oral formulations from concept idea until clinical proof of concept.
Beyond the preview
Go deeper on Solural Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solural Pharma.